• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    10 Health Care Stocks With Whale Alerts In Today's Session

    7/1/24 1:35:22 PM ET
    $ALNY
    $BMY
    $CRNX
    $DHR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ALNY alert in real time by email

    This whale alert can help traders discover the next big trading opportunities.

    Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

    Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels.

    Here's the list of options activity happening in today's session:

    Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
    CRNX CALL TRADE BEARISH 09/20/24 $50.00 $660.0K 236 2.8K
    HIMS CALL TRADE BEARISH 07/05/24 $22.00 $88.7K 856 1.6K
    DHR PUT SWEEP NEUTRAL 07/12/24 $247.50 $80.6K 1.0K 622
    UNH PUT TRADE BEARISH 07/12/24 $485.00 $29.7K 56 259
    ALNY CALL TRADE NEUTRAL 07/19/24 $185.00 $71.4K 1.0K 150
    IQV PUT SWEEP BULLISH 07/19/24 $210.00 $33.1K 2.5K 35
    BMY PUT SWEEP BULLISH 08/16/24 $41.00 $33.6K 3.6K 32
    SAVA CALL TRADE BEARISH 01/16/26 $12.50 $1.5 million 839 28
    LLY CALL TRADE NEUTRAL 01/17/25 $900.00 $30.3K 1.5K 9
    ISRG PUT TRADE BULLISH 01/17/25 $440.00 $29.6K 50 0

    Explanation

    These itemized elaborations have been created using the accompanying table.

    • For CRNX (NASDAQ:CRNX), we notice a call option trade that happens to be bearish, expiring in 81 day(s) on September 20, 2024. This event was a transfer of 2200 contract(s) at a $50.00 strike. The total cost received by the writing party (or parties) was $660.0K, with a price of $300.0 per contract. There were 236 open contracts at this strike prior to today, and today 2880 contract(s) were bought and sold.

    • Regarding HIMS (NYSE:HIMS), we observe a call option trade with bearish sentiment. It expires in 4 day(s) on July 5, 2024. Parties traded 4438 contract(s) at a $22.00 strike. The total cost received by the writing party (or parties) was $88.7K, with a price of $20.0 per contract. There were 856 open contracts at this strike prior to today, and today 1684 contract(s) were bought and sold.

    • Regarding DHR (NYSE:DHR), we observe a put option sweep with neutral sentiment. It expires in 11 day(s) on July 12, 2024. Parties traded 152 contract(s) at a $247.50 strike. This particular put needed to be split into 15 different trades to become filled. The total cost received by the writing party (or parties) was $80.6K, with a price of $530.0 per contract. There were 1019 open contracts at this strike prior to today, and today 622 contract(s) were bought and sold.

    • For UNH (NYSE:UNH), we notice a put option trade that happens to be bearish, expiring in 11 day(s) on July 12, 2024. This event was a transfer of 99 contract(s) at a $485.00 strike. The total cost received by the writing party (or parties) was $29.7K, with a price of $300.0 per contract. There were 56 open contracts at this strike prior to today, and today 259 contract(s) were bought and sold.

    • For ALNY (NASDAQ:ALNY), we notice a call option trade that happens to be neutral, expiring in 18 day(s) on July 19, 2024. This event was a transfer of 12 contract(s) at a $185.00 strike. The total cost received by the writing party (or parties) was $71.4K, with a price of $5950.0 per contract. There were 1086 open contracts at this strike prior to today, and today 150 contract(s) were bought and sold.

    • For IQV (NYSE:IQV), we notice a put option sweep that happens to be bullish, expiring in 18 day(s) on July 19, 2024. This event was a transfer of 77 contract(s) at a $210.00 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $33.1K, with a price of $430.0 per contract. There were 2558 open contracts at this strike prior to today, and today 35 contract(s) were bought and sold.

    • For BMY (NYSE:BMY), we notice a put option sweep that happens to be bullish, expiring in 46 day(s) on August 16, 2024. This event was a transfer of 200 contract(s) at a $41.00 strike. This particular put needed to be split into 29 different trades to become filled. The total cost received by the writing party (or parties) was $33.6K, with a price of $168.0 per contract. There were 3612 open contracts at this strike prior to today, and today 32 contract(s) were bought and sold.

    • Regarding SAVA (NASDAQ:SAVA), we observe a call option trade with bearish sentiment. It expires in 564 day(s) on January 16, 2026. Parties traded 1999 contract(s) at a $12.50 strike. The total cost received by the writing party (or parties) was $1.5 million, with a price of $755.0 per contract. There were 839 open contracts at this strike prior to today, and today 28 contract(s) were bought and sold.

    • For LLY (NYSE:LLY), we notice a call option trade that happens to be neutral, expiring in 200 day(s) on January 17, 2025. This event was a transfer of 3 contract(s) at a $900.00 strike. The total cost received by the writing party (or parties) was $30.3K, with a price of $10126.0 per contract. There were 1599 open contracts at this strike prior to today, and today 9 contract(s) were bought and sold.

    • For ISRG (NASDAQ:ISRG), we notice a put option trade that happens to be bullish, expiring in 200 day(s) on January 17, 2025. This event was a transfer of 9 contract(s) at a $440.00 strike. The total cost received by the writing party (or parties) was $29.6K, with a price of $3292.0 per contract. There were 50 open contracts at this strike prior to today, and today 0 contract(s) were bought and sold.

    Options Alert Terminology
    - Call Contracts: The right to buy shares as indicated in the contract.
    - Put Contracts: The right to sell shares as indicated in the contract.
    - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it.
    - Premium/Option Price: The price of the contract.

    For more information, visit our Guide to Understanding Options Alerts or read more news on unusual options activity.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ALNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALNY
    $BMY
    $CRNX
    $DHR

    CompanyDatePrice TargetRatingAnalyst
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$24.00Sell → Neutral
    Citigroup
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$23.00Underperform → Neutral
    BofA Securities
    Hims & Hers Health Inc.
    $HIMS
    3/9/2026$30.00Hold → Buy
    Needham
    IQVIA Holdings Inc.
    $IQV
    3/9/2026$213.00Hold → Buy
    TD Cowen
    IQVIA Holdings Inc.
    $IQV
    3/6/2026$210.00Equal Weight → Overweight
    Barclays
    IQVIA Holdings Inc.
    $IQV
    3/3/2026$221.00Outperform
    RBC Capital Mkts
    Eli Lilly and Company
    $LLY
    2/25/2026$1250.00Outperform
    RBC Capital Mkts
    Bristol-Myers Squibb Company
    $BMY
    2/25/2026$60.00Sector Perform
    RBC Capital Mkts
    More analyst ratings

    $ALNY
    $BMY
    $CRNX
    $DHR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hims & Hers Health upgraded by Citigroup with a new price target

    Citigroup upgraded Hims & Hers Health from Sell to Neutral and set a new price target of $24.00

    3/10/26 8:37:35 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Hims & Hers Health from Underperform to Neutral and set a new price target of $23.00

    3/10/26 8:37:14 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by Needham with a new price target

    Needham upgraded Hims & Hers Health from Hold to Buy and set a new price target of $30.00

    3/9/26 11:28:34 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP & Chief Mfg and Supply Cha Brosius Mark sold $630,475 worth of shares (1,293 units at $487.61), decreasing direct ownership by 44% to 1,613 units (SEC Form 4)

    4 - INTUITIVE SURGICAL INC (0001035267) (Issuer)

    3/10/26 2:24:12 PM ET
    $ISRG
    Industrial Specialties
    Health Care

    EVP Chief R&D Garg Pushkal sold $1,524,796 worth of shares (4,713 units at $323.53), decreasing direct ownership by 20% to 18,693 units (SEC Form 4)

    4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Issuer)

    3/6/26 4:13:37 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Greenstreet Yvonne sold $947,581 worth of shares (2,933 units at $323.08), decreasing direct ownership by 3% to 95,695 units (SEC Form 4)

    4 - ALNYLAM PHARMACEUTICALS, INC. (0001178670) (Issuer)

    3/6/26 4:13:11 PM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 26, 2024 - FDA Approves Drug with New Mechanism of Action for Treatment of Schizophrenia

    For Immediate Release: September 26, 2024 Today, the U.S. Food and Drug Administration approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults. It is the first antipsychotic drug approved to treat schizophrenia that targets cholinergic receptors as opposed to dopamine receptors, which has long been the standard of care.   “Schizophrenia is a leading

    9/26/24 6:42:20 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    SEC Filings

    View All

    Cassava Sciences Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - FILANA THERAPEUTICS, INC. (0001069530) (Filer)

    3/10/26 8:15:27 AM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Regulation FD Disclosure

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    3/9/26 4:33:13 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form PRE 14A filed by Eli Lilly and Company

    PRE 14A - ELI LILLY & Co (0000059478) (Filer)

    3/6/26 4:35:56 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hims & Hers Names Kathryn Beiser as Chief Communications Officer

    The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

    3/10/26 8:08:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Introducing Hims & Hers Benefits, Unlocking Health & Wellness Discounts for Subscribers

    The program debuts with Prenuvo and Eight Sleep, providing discounts on advanced diagnostics and sleep technology Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced Hims & Hers Benefits, a new way for subscribers to access the best innovations in whole body health. This new initiative provides active subscribers access to discounts from health partners, all in one place, including whole body MRI scans from Prenuvo and adaptive bed systems from Eight Sleep. This is just the beginning of a larger benefits program that will make comprehensive, holistic care more accessible and affordable for subscribers. "True health doesn't happen in a vacuum.

    3/10/26 9:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Alnylam to Webcast TTR Investor Webinar

    Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), the leading RNAi therapeutics company, announced today that it will webcast its upcoming TTR Investor Webinar on the Investors section of the Company's website, www.alnylam.com, on Tuesday, March 24, 2026 at 9:30 am ET. A replay will be available on the Alnylam website within 48 hours after the event. The TTR Investor Webinar, marking one year since U.S. FDA approval of AMVUTTRA® in ATTR-CM, will highlight Alnylam's progress in delivering for patients with ATTR-CM, as well as the long-term growth and durability of the Company's flagship TTR franchise. The webinar will feature Alnylam's senior commercial and medical leaders, including: Tolg

    3/10/26 8:00:00 AM ET
    $ALNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Anderson Robert Eugene Jr bought $24,940 worth of shares (8,600 units at $2.90) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/25/25 4:06:25 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $414,000 worth of shares (150,000 units at $2.76) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/24/25 4:02:17 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    President & CEO Barry Richard bought $201,809 worth of shares (73,385 units at $2.75) (SEC Form 4)

    4 - CASSAVA SCIENCES INC (0001069530) (Issuer)

    11/20/25 5:39:26 PM ET
    $SAVA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Names Kathryn Beiser as Chief Communications Officer

    The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

    3/10/26 8:08:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Announces Agreement to Acquire Eucalyptus, Accelerating Its Vision to Become the Leading Global Consumer Health Platform

    Eucalyptus is a consumer healthcare leader in Australia, the UK and Germany, with expanding new operations in Japan and Canada. Hims & Hers Health, Inc. (NYSE:HIMS), the leading health and wellness platform, today announced it has entered into a definitive agreement to acquire Eucalyptus, an international leader in digital health, accelerating the company's ability to bring access to high-quality, personalized care to more people across the world. As its US business continues to grow, Hims & Hers will be well-positioned, upon closing of the acquisition, to expand into Australia and Japan and deepen its presence in the UK, Germany, and Canada. The terms of the transaction have been structu

    2/19/26 6:00:00 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Danaher To Acquire Masimo Corporation

    WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE:DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo Corporation (NASDAQ:MASI) a leading specialty diagnostics provider of pulse oximetry and other patient monitoring solutions, primarily in acute care settings. Under the terms of the agreement, Danaher will acquire all of the outstanding shares of Masimo common stock for $180 per share in cash, or a total enterprise value of approximately $9.9 billion including assumed indebtedness and net of acquired cash. This represents a transaction multiple of approximately 18x estimated 2027 EBITDA, or 15x 2

    2/17/26 8:00:00 AM ET
    $DHR
    $MASI
    Industrial Machinery/Components
    Industrials
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 7:55:29 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Crinetics Pharmaceuticals Inc.

    SC 13G/A - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 5:46:54 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Crinetics Pharmaceuticals Inc.

    SC 13G - Crinetics Pharmaceuticals, Inc. (0001658247) (Subject)

    11/14/24 1:22:38 PM ET
    $CRNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALNY
    $BMY
    $CRNX
    $DHR
    Financials

    Live finance-specific insights

    View All

    Bristol Myers Squibb Announces Dividend

    Bristol Myers Squibb (NYSE:BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-three cents ($0.63) per share on the $0.10 par value common stock of the company. The dividend is payable on May 1, 2026, to stockholders of record at the close of business on April 2, 2026. About Bristol Myers Squibb: Transforming Patients' Lives Through Science At Bristol Myers Squibb, our mission is to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what's possible for the future of medicine and the patients we serve. For more information about Bristol Myers Squibb, visit u

    3/2/26 4:16:00 PM ET
    $BMY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options

    NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 25, 2026 /CNW/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.  Ashley Mastronardi delivers the pre-market update on February 25thEquities are higher Wednesday morning as Nvidia prepares to release its fourth quarter earnings after market close.MSCI Emerging Markets Index Options and MSCI EAFE Index Options are set to begin trading on NYSE Arca Options today under the ticker symbols MXEF and MXEADynatrace (NYSE:DT) CEO Rick McConnell will

    2/25/26 8:55:00 AM ET
    $BMY
    $DT
    $ICE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on March 17, 2026, to all shareholders of record of UNH common stock as of the close of business March 9, 2026. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health

    2/25/26 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care